Emerging retatrutide, a dual -action treatment targeting equally GLP-1 and GIP receptors, is sparking considerable interest within the weight loss community. Initial clinical studies have revealed significant decreases in body mass and gains in health markers for people with overweight. Experts believe this novel approach may represent a signifi… Read More